Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.

Abstract

In this independent prospective randomized trial, we compared the clinical effectiveness, functional outcome and patient satisfaction following intra articular injection with two viscosupplementation agents - Hylan G-F-20 (n=199) and Sodium Hyaluronate (n=193) in patients with osteoarthritis (OA) of the knee. All patients were prospectively reviewed by blinded independent assessors at pre injection, 6 weeks, 3, 6, 12 months. Knee pain and patient satisfaction were measured on a visual analogue scale. Functional outcome was assessed using WOMAC, Oxford knee score and EuroQol EQ-5D scores. Knee pain on VAS improved from 6.7 to 3.2 by 6 weeks (p=0.02) and was sustained until 12 months (3.7, p=0.04) with Hylan G-F 20. In the Sodium Hyaluronate group, pain improved from 6.6 to 5.7 at 6 weeks (p>0.05) and to 4.1 at 3 months (p=0.04) but was sustained only until 6 months (5.9, p>0.05). Improvement in the WOMAC pain subscale was significantly superior in the Hylan G-F 20 group at 3 months (p=0.02), 6 months (p=0.01) and 12 months (p=0.007). There was no significant difference in the EQ-5D scores at 6 weeks and 3 months between the two groups. The numbers of treatment related adverse events were higher (39 vs. 30) in the Hylan G-F 20 group. One patient in the Hylan G-F 20 group who had a serious adverse event was also included in the final analysis. Although both treatments offered significant pain reduction, it was achieved earlier and sustained for a longer period with Hylan G-F 20. From this study, it appeared that the clinical effectiveness and general patient satisfaction are better amongst patients who received Hylan G-F 20.

• Authors: R Raman, A Dutta, N Day, H K Sharma, C J Shaw, G V Johnson
• Journal: The Knee (Knee) Vol. 15 Issue 4 Pg. 318-24 (Aug 2008) ISSN: 0968-0160 [Print] Netherlands
• PMID: 18430574 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Biocompatible Materials
• hylan
• Hyaluronic Acid

Topics

• Biocompatible Materials (administration & dosage, therapeutic use)
• Follow-Up Studies
• Humans
• Hyaluronic Acid (administration & dosage, analogs & derivatives, therapeutic use)
• Middle Aged
• Osteoarthritis, Knee (drug therapy)
• Patient Satisfaction
• Prospective Studies
• Range of Motion, Articular
• Recovery of Function
• Treatment Outcome
• Viscosupplementation